Thyroid cancer in Friuli Venezia Giulia, northeastern Italy: incidence, overdiagnosis, and impact of type of surgery on survival

Background: Incidence rates of thyroid cancer (TC) increased in the last decades worldwide. This study aimed to describe TC incidence in the Friuli Venezia Giulia (FVG) region, to estimate the quota of overdiagnosis, and to investigate the impact of surgery on long-term survival after TC diagnosis. Methods: TC cases reported to the FVG population-based cancer registry during 2002–2013, aged <85 years, were included. Age standardized rates (ASR) on the European population were computed, while proportion of TC overdiagnosis was estimated in comparison with expected age-specific incidence rates from published time series. Adjusted hazard ratios of death, with 95% confidence intervals, were also estimated. Results: During 2002–2013, 1701 TC cases were reported to the FVG cancer registry, with papillary TC (78.2%) as the most frequent histologic type. ASR increased from 12.4 to 16.5 in women and from 4.3 to 6.2 in men (+33.1% and +44.2%, respectively). Overdiagnosis was estimated as 79% of TC cases in women and 64% in men. Almost all TC cases (97.1%) underwent surgery, including 84.6% of women and 78.9% of men who underwent total thyroidectomy. Up to 10 years after TC diagnosis, the type of surgery did not appear to influence survival. Conclusions: This study documented an increase in TC incidence in FVG in the last decade, with overdiagnosis accounting for a large proportion of TC diagnoses and total thyroidectomy in more than 80% of cases. These findings suggest reconsidering thyroid screening practice and aggressive therapeutic strategies, as recommended by new TC guidelines.

[1]  H. Welch,et al.  Saving Thyroids - Overtreatment of Small Papillary Cancers. , 2018, The New England journal of medicine.

[2]  E. Papini,et al.  Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies , 2018, Journal of Endocrinological Investigation.

[3]  S. Rosso,et al.  The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998-2012. , 2018, European journal of cancer.

[4]  S. Filetti Faculty of 1000 evaluation for Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. , 2018 .

[5]  T. Montesano,et al.  Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. , 2017, Thyroid : official journal of the American Thyroid Association.

[6]  David F. Schneider,et al.  Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes. , 2017, The Journal of surgical research.

[7]  S. Hawley,et al.  Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment? , 2017, The New England journal of medicine.

[8]  NickelBrooke,et al.  Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study. , 2017 .

[9]  B. Fabris,et al.  Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? , 2017, International journal of surgery.

[10]  D. Serraino,et al.  Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. , 2017, European journal of cancer.

[11]  S. Devesa,et al.  Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 , 2017, JAMA.

[12]  Jennifer S. Lin,et al.  Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force , 2017, JAMA.

[13]  Hyunsoon Cho,et al.  Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study , 2016, British Medical Journal.

[14]  H. Ahn,et al.  Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality. , 2016, Thyroid : official journal of the American Thyroid Association.

[15]  P. Prorok,et al.  Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. , 2016, The New England journal of medicine.

[16]  Martyn Plummer,et al.  Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. , 2016, The New England journal of medicine.

[17]  A. Miyauchi,et al.  Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery , 2016, Thyroid : official journal of the American Thyroid Association.

[18]  Ruth Etzioni,et al.  Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them. , 2015, Journal of the National Cancer Institute.

[19]  T. Fahey,et al.  Cost disparity between health care systems--it's not the surgeons: A cost analysis of thyroid cancer care between the United States and France. , 2016, Surgery.

[20]  F. Boscoe,et al.  Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011 , 2015, International journal of cancer.

[21]  I. Ganly,et al.  Cost‐effectiveness analysis of papillary thyroid cancer surveillance , 2015, Cancer.

[22]  M. Plummer,et al.  The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries. , 2015, Thyroid : official journal of the American Thyroid Association.

[23]  Hyeong Sik Ahn,et al.  Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. , 2014, The New England journal of medicine.

[24]  S. Roman,et al.  Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival: An Analysis of 61,775 Patients , 2014, Annals of surgery.

[25]  M. Federico,et al.  Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  M. Pelizzo,et al.  Thyroid surgical practices shaping thyroid cancer incidence in North-Eastern Italy. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  Victor M Montori,et al.  Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours , 2013, BMJ.

[28]  S. Stordeur,et al.  Regional variation in thyroid cancer incidence in Belgium is associated with variation in thyroid imaging and thyroid disease management. , 2013, The Journal of clinical endocrinology and metabolism.

[29]  P. Pezzotti,et al.  Increased incidence of thyroid cancer in Latina, Italy: a possible role of detection of subclinical disease. , 2013, Cancer epidemiology.

[30]  M. Michiara,et al.  Thyroid cancer incidence by histological type and related variants in a mildly iodine‐deficient area of Northern Italy, 1998 to 2009 , 2012, Cancer.

[31]  S. Franceschi,et al.  Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  H. Welch,et al.  Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.

[33]  A. Pinchera,et al.  Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. , 2010, The Journal of clinical endocrinology and metabolism.

[34]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[35]  Herb Chen,et al.  Papillary Thyroid Microcarcinomas: Big Decisions for a Small Tumor , 2009, Annals of Surgical Oncology.

[36]  S. Hall,et al.  Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease , 2007, Canadian Medical Association Journal.

[37]  W. Wiersinga,et al.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.

[38]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[39]  D. Purdie Statistical Methods in Medical Research, 4th edn , 2003 .

[40]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .

[41]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[42]  R. Gray A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[43]  P. Armitage Statistical methods in medical research. , 1972 .